Category Archives: Pharma

Biopharma innovation: Trying things out quickly and effectively

Image via Wikipedia Every all-hands meeting I learn something new. This time the word that I heard Jeff Bezos use was trystorming, described as brainstorming, except that instead of talking about things you actually try things out. That’s something that most of us can relate to. Many of us spend too much time [...]
Also posted in BioIT, Biopharma innovation, Innovation | Leave a comment

Biopharma innovation: Open drug discovery? Not yet, but maybe some day

Interesting post from Joerg, who is not so sure about open innovation in drug design. He makes some good points, with the observation In other words, if you do not need the money, do whatever you like openly. If you need the money, e.g. for clinical trials, then please make sure staying within the [...]
Also posted in Biopharma innovation, Drug Development, IP, Innovation, Open Science | Leave a comment

Biopharma innovation: A marketplace for discontinued drug programs

Image via Wikipedia So I am supposed to be writing about innovation in the Biopharma industry. Here’s in idea that I’ve had that might be worth discussing (sometimes I wish I had the patience to write with the depth of Michael Nielsen). Last year we heard about Goldman Sachs funding an innovative pharma business model, [...]
Also posted in Biopharma innovation, Drug Development, Industry, Innovation | Leave a comment

Innovation, biotech, software, etc

Image via Wikipedia Chris asked me to talk about biotech and innovation, so I don’t really have a choice. This is just a preamble, and more will come down the road. Over the years, I have talked a lot about innovation, especially in the life sciences. Earlier today, I started a bit of [...]
Also posted in Biotech, Drug Development, Innovation | Leave a comment

Goldman’s pool for drug research

And while we are on the subject of blog posts by Derek Lowe, here’s one where he points to news about Goldman Sachs funding a large pharma company and using a “new” business model (The model involves) a different approach, creating a “research pool” into which pharma companies would place a range of experimental drugs in [...]
Also posted in Drug Development, Innovation | 2 Comments
  • Archives